INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 436m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN35m ago
Public company

ADRXADARx Pharmaceuticals, Inc.

CIK 0001802369

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 0
Max Insider Score9
Connections6with evidence

ADRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MR
MacLeod Alan RobertChief Scientific Officer
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
170.7K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    MacLeod Alan RobertChief Scientific Officer · Sep 28, 2026
  • ← Insider ofevidence
    Zhu Rui (NMN)Chief Technology Officer · Sep 28, 2026
  • ← Insider ofevidence
    Ackles Robert WilliamChief People Officer · Sep 28, 2026
9
ZN
Zhu Rui (NMN)Chief Technology Officer
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A
—
512.1K sh
Sep 24, 2026
Sep 28, 2026
traded Sep 24, 2026
+4d
SEC FORM 4

Evidence

9
FR
Fisk RyanCFO and CBO
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
170.7K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

9
AW
Ackles Robert WilliamChief People Officer
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
85.3K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

9
LZ
Li ZhenDirector, President and CEO, 10% Owner
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
1.02M sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Fisk RyanCFO and CBO · Sep 28, 2026
  • ← Insider ofevidence
    Li ZhenDirector, President and CEO, 10% Owner · Sep 28, 2026